8th IPCRG Clinical Practice Webinar & Abstract Presentations
COVID-19 & the Importance of Public Information and Education in Primary Care
Presenters: Sundeep Salvi, India & Javiera Corbalán, Chile
Saturday 4 July 2020, 1500-1700hrs BST
|
|
On Saturday 4 July we will hold the final webinar in the current IPCRG series. This webinar will cover the very topical area of COVID-19 & the Importance of Public Information and Education in Primary Care and we are delighted to welcome two IPCRG colleagues, Sundeep Salvi from India & Javiera Corbalán from Chile, who will share their experiences.
|
|
|
Sundeep trained as a Pulmonologist and is the Director of Pulmocare Research and Education Foundation (PURE), based in Pune.
|
|
Javiera is a family doctor and works in a Paediatric Emergency Department and at the Universidad Austral de Chile.
|
|
Both our presenters are speaking from countries tackling significant COVID-19 problems and we are grateful to them for taking the time to share their knowledge and experience with the IPCRG community. They will each present their country’s perspective on the main public information/education challenges for primary care and public health including: managing misinformation; role of social media; political versus health decisions; best practices; and recommendations for primary care when dealing with individual patients and populations. Between them, they will give an update on key topics such as public information on symptoms, physical distancing, hand washing and masks. We invite attendees to share their experiences, evidence and questions.
|
|
These presentations will be followed by six of the most highly ranked abstracts previously selected for presentation at 10th IPCRG World Conference, due to have been held in Dublin earlier this year. These webinars are enabling researchers to share their work with you, an international audience, whilst gaining important peer review that otherwise might have been missed during the current pandemic.
So please join us by registering at: https://www.ipcrg.org/conferences/ipcrg-2020-virtual-conference-sessions
|
|
Programme, Saturday 4 July 2020
|
Timing BST |
Welcome |
Janwillem Kocks, President-Elect IPCRG |
1500-1505 |
Plenary Session 1 |
COVID-19 & the Importance of Public Information and Education in Primary Care: The Indian experience, and an update on physical distancing, handwashing and masks
Presenter: Sundeep Salvi, India. |
1505-1520 |
Plenary Session 2 |
COVID-19 & the Importance of Public Information and Education in Primary Care: The Chilean experience, and an update on information about symptoms and testing
Presenter: Javiera Corbalán, Chile. |
1520-1535 |
|
Discussion with Q&A |
1535-1550 |
Video & Comfort Break |
Oral Abstracts |
- Ademgenoot – A serious game to motivate and empower asthma patients in adherence to their maintenance medication: A user-centered design study Charlotte Poot, The Netherlands
|
1600-1610 |
|
- Virtual Home-Based Pulmonary Rehabilitation Programme for COPD Patients Cathy Gillen, Ireland
|
1610-1620 |
|
- Prevalence of vitamin D deficiency and insufficiency in patients with chronic obstructive pulmonary disease Malek Chaabouni, Tunisia
|
1620-1630 |
|
- Chronic respiratory disease (CRD) surveys in low- and middle-income countries (LMICs): A systematic scoping review of methodologies and outcomes Nik Sherina Hanafi, Malaysia
|
1630-1640 |
|
- Development and validation of reference equations for lung function in healthy Sri Lankan Tamils Mathanki Sooriyakanthan, Sri Lanka
|
1640-1650 |
|
- Assessing feasibility of methods to estimate cost of illness of COPD in western rural India Ankita Shrivastava, India
|
1650-1700 |
Close |
Janwillem Kocks, President-Elect IPCRG |
1700-1705 |
|
|
All resources from previous IPCRG webinars, including the presentations and session recordings, can be found by following the links below:
16 May |
COVID-19 in Primary Care: Supporting those Suffering & Recovering Presenters: Steve Holmes, UK & Matthieu Bremond, France |
23 May |
COVID-19 in Primary Care: Supporting People’s Mental Health Presenters: Lindsay Ip, UK & Jaime Correia de Sousa, Portugal |
30 May |
COVID-19 in Primary Care: Protecting the Most Vulnerable Presenters: Hanna Sandelowsky, Sweden & Chunhua Chi, China |
6 June |
COVID-19 & the Primary Care Management of Asthma Presenters: Dermot Nolan, Ireland & Alan Kaplan, Canada |
13 June |
COVID-19 & the Challenges of Diagnosing Asthma in Primary Care Presenters: Luke Daines, UK & Jim Stout, USA |
20 June |
COVID-19 & Diagnosis and Management of COPD in Primary Care Presenters: Hilary Pinnock & Vince Mak, UK |
27 June |
The Impact of Nicotine & Smoking in COVID-19 & Chronic Respiratory Diseases (Asthma & COPD): A Conversation & Case Study Discussion Presenters: Noel Baxter & Darush Attar-Zadeh, UK |
|
|
I PCRG also has frequently updated resources on many aspects of COVID-19. These can be accessed by following this link: https://www.ipcrg.org/news/covid-19-open-source-sources-of-information. There are a wide variety of resources including:
- Expert Recommendations for the Prevention and Control of COVID-19 Infections in Primary Care (First Edition)
- Handbook on COVID-19 Infection, Prevention and Control in Communities: Compiled and published by the Bureau of Disease Prevention and Control of National Health Commission of People’s Republic of China
|
|
IPCRG would like to express their appreciation to Astra Zeneca for supporting this, and three of the other webinars, during this series.
|
|
Respiratory & Immunology is one of AstraZeneca’s three therapy areas and is a key growth driver for the Company.
AstraZeneca is an established leader in respiratory care, and its inhaled and biologic medicines reached more than 53 million patients in 2019. Building on a 50-year heritage, the Company aims to transform the treatment of asthma and COPD by focusing on earlier biology-led treatment, eliminating preventable asthma attacks, and removing COPD as a top-three leading cause of death. The Company’s early respiratory research is focused on emerging science involving immune mechanisms, lung damage and abnormal cell repair processes in disease and neuronal dysfunction.
With common pathways and underlying disease drivers across respiratory and immunology, AstraZeneca is following the science from chronic lung diseases to immunology-driven disease areas. The Company’s growing presence in immunology is focused on five mid- to late-stage franchises with multi-disease potential, in areas including rheumatology (including lupus), dermatology, gastroenterology, and systemic eosinophilic-driven diseases. AstraZeneca’s ambition in Respiratory & Immunology is to achieve disease modification and durable remission for millions of patients worldwide.
|
|
Go to www.ipcrg.org to find out more about the IPCRG, a charity working locally in primary care and collaborating globally to improve respiratory health so that we can achieve our vision of a global population breathing and feeling well through universal access to right care.
We look forward to seeing you at the webinar on Saturday 4 July and on behalf of us all at IPCRG, we would like to thank you for supporting us over the past two months.
Keep well, stay safe.
|
|
Ioanna Tsiligianni
President IPCRG
Siân Williams
CEO IPCRG
|
|
|
|